ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,579, issued on Nov. 18, was assigned to MICROBIOPHARM JAPAN Co. LTD. (Tokyo).
"Method for enzymatically producing maytansinol" was invented by Yutaro Baba (Tokyo), Kenji Nishimura (Tokyo), Yuta Miki (Tokyo), Yukie Kawasaki (Tokyo), Tsuyoshi Yamamoto (Tokyo), Mayu Kawasaki (Shizuoka, Japan), Shogo Nakano (Shizuoka, Japan) and Sohei Ito (Shizuoka, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "A technique relating to a method for enzymatically producing maytansinol from an ansamitocin species, such as AP3, is provided. The method for producing maytansinol includes enzymatically producing maytansinol from an ansamitocin species with any one of va...